Cargando…

OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review

PURPOSE: Medical staging, surgical planning, and therapeutic decisions are significantly different for brain metastases versus gliomas. Machine learning (ML) algorithms have been developed to differentiate these pathologies. We performed a systematic review to characterize ML methods and to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Brim, Waverly Rose, Jekel, Leon, Petersen, Gabriel Cassinelli, Subramanian, Harry, Zeevi, Tal, Payabvash, Sam, Bousabarah, Khaled, Lin, MingDe, Cui, Jin, Brackett, Alexandria, Mahajan, Ajay, Johnson, Michele, Mahajan, Amit, Aboian, Mariam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351249/
http://dx.doi.org/10.1093/noajnl/vdab071.067
_version_ 1783735933567238144
author Brim, Waverly Rose
Jekel, Leon
Petersen, Gabriel Cassinelli
Subramanian, Harry
Zeevi, Tal
Payabvash, Sam
Bousabarah, Khaled
Lin, MingDe
Cui, Jin
Brackett, Alexandria
Mahajan, Ajay
Johnson, Michele
Mahajan, Amit
Aboian, Mariam
author_facet Brim, Waverly Rose
Jekel, Leon
Petersen, Gabriel Cassinelli
Subramanian, Harry
Zeevi, Tal
Payabvash, Sam
Bousabarah, Khaled
Lin, MingDe
Cui, Jin
Brackett, Alexandria
Mahajan, Ajay
Johnson, Michele
Mahajan, Amit
Aboian, Mariam
author_sort Brim, Waverly Rose
collection PubMed
description PURPOSE: Medical staging, surgical planning, and therapeutic decisions are significantly different for brain metastases versus gliomas. Machine learning (ML) algorithms have been developed to differentiate these pathologies. We performed a systematic review to characterize ML methods and to evaluate their accuracy. METHODS: Studies on the application of machine learning in neuro-oncology were searched in Ovid Embase, Ovid MEDLINE, Cochrane trials (CENTRAL) and Web of science core-collection. A search strategy was designed in compliance with a clinical librarian and confirmed by a second librarian. The search strategy comprised of controlled vocabulary including artificial intelligence, machine learning, deep learning, magnetic resonance imaging, and glioma. The initial search was performed in October 2020 and then updated in February 2021. Candidate articles were screened in Covidence by at least two reviewers each. A bias analysis was conducted in agreement with TRIPOD, a bias assessment tool similar to CLAIM. RESULTS: Twenty-nine articles were used for data extraction. Four articles specified model development for solitary brain metastases. Classical ML (cML) algorithms represented 85% of models used, while deep learning (DL) accounted for 15%. cML algorithms performed with an average accuracy, sensitivity, and specificity of 82%, 78%, 88%, respectively; DL performed 84%, 79%, 81%. The support vector machine (SVM) algorithm was the most common used cML model in the literature and convolutional neural networks (CNN) were standard for DL models. We also found T1, T1 post-gadolinium and T2 sequences were most commonly used for feature extraction. Preliminary TRIPOD analysis yielded an average score of 14.25 (range 8–18). CONCLUSION: ML algorithms that can accurately classify glioma from brain metastases have been developed. SVM and CNN are leading approaches with high accuracy. Standardized algorithm performance reporting is a clear limitation to be addressed in future studies.
format Online
Article
Text
id pubmed-8351249
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-83512492021-08-09 OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review Brim, Waverly Rose Jekel, Leon Petersen, Gabriel Cassinelli Subramanian, Harry Zeevi, Tal Payabvash, Sam Bousabarah, Khaled Lin, MingDe Cui, Jin Brackett, Alexandria Mahajan, Ajay Johnson, Michele Mahajan, Amit Aboian, Mariam Neurooncol Adv Supplement Abstracts PURPOSE: Medical staging, surgical planning, and therapeutic decisions are significantly different for brain metastases versus gliomas. Machine learning (ML) algorithms have been developed to differentiate these pathologies. We performed a systematic review to characterize ML methods and to evaluate their accuracy. METHODS: Studies on the application of machine learning in neuro-oncology were searched in Ovid Embase, Ovid MEDLINE, Cochrane trials (CENTRAL) and Web of science core-collection. A search strategy was designed in compliance with a clinical librarian and confirmed by a second librarian. The search strategy comprised of controlled vocabulary including artificial intelligence, machine learning, deep learning, magnetic resonance imaging, and glioma. The initial search was performed in October 2020 and then updated in February 2021. Candidate articles were screened in Covidence by at least two reviewers each. A bias analysis was conducted in agreement with TRIPOD, a bias assessment tool similar to CLAIM. RESULTS: Twenty-nine articles were used for data extraction. Four articles specified model development for solitary brain metastases. Classical ML (cML) algorithms represented 85% of models used, while deep learning (DL) accounted for 15%. cML algorithms performed with an average accuracy, sensitivity, and specificity of 82%, 78%, 88%, respectively; DL performed 84%, 79%, 81%. The support vector machine (SVM) algorithm was the most common used cML model in the literature and convolutional neural networks (CNN) were standard for DL models. We also found T1, T1 post-gadolinium and T2 sequences were most commonly used for feature extraction. Preliminary TRIPOD analysis yielded an average score of 14.25 (range 8–18). CONCLUSION: ML algorithms that can accurately classify glioma from brain metastases have been developed. SVM and CNN are leading approaches with high accuracy. Standardized algorithm performance reporting is a clear limitation to be addressed in future studies. Oxford University Press 2021-08-09 /pmc/articles/PMC8351249/ http://dx.doi.org/10.1093/noajnl/vdab071.067 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Abstracts
Brim, Waverly Rose
Jekel, Leon
Petersen, Gabriel Cassinelli
Subramanian, Harry
Zeevi, Tal
Payabvash, Sam
Bousabarah, Khaled
Lin, MingDe
Cui, Jin
Brackett, Alexandria
Mahajan, Ajay
Johnson, Michele
Mahajan, Amit
Aboian, Mariam
OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
title OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
title_full OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
title_fullStr OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
title_full_unstemmed OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
title_short OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
title_sort othr-12. the development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351249/
http://dx.doi.org/10.1093/noajnl/vdab071.067
work_keys_str_mv AT brimwaverlyrose othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT jekelleon othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT petersengabrielcassinelli othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT subramanianharry othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT zeevital othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT payabvashsam othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT bousabarahkhaled othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT linmingde othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT cuijin othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT brackettalexandria othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT mahajanajay othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT johnsonmichele othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT mahajanamit othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview
AT aboianmariam othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview